UNIVERSITY OF ARIZONA

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1885-01-01

Employees: 10K

Market Cap: -

Website: http://www.arizona.edu

Clinical Trials

Improving the Appearance of Skin and Hair in Patients Undergoing Valley Fever Treatment

Not Applicable

Terminated

Conditions: Coccidioidomycosis
Valley Fever

Interventions: Other: Cholesterol-containing moisturizers

First Posted Date: 2018-08-07

Last Posted Date: 2021-06-04

Lead Sponsor: University of Arizona

Target Recruit Count: 14

Registration Number: NCT03618992

Locations: 🇺🇸
Valley Fever Center for Excellence, Tucson, Arizona, United States
🇺🇸
University of Arizona - Banner University Medicine Dermatology, Tucson, Arizona, United States

Alpelisib in Treating Participants With Transorally Resectable HPV-Associated Stage I-IVA Oropharyngeal Cancer

Phase 2

Terminated

Conditions: Stage I Oropharyngeal Squamous Cell Carcinoma AJCC V7
Stage II Oropharyngeal Squamous Cell Carcinoma AJCC V7
CDKN2A-p16 Positive
HPV Positive Oropharyngeal Squamous Cell Carcinoma
Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7
Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7

Interventions: Drug: Alpelisib
Other: Laboratory Biomarker Analysis
Other: Pharmacodynamic Study
Procedure: Therapeutic Conventional Surgery

First Posted Date: 2018-07-26

Last Posted Date: 2024-04-17

Lead Sponsor: University of Arizona

Target Recruit Count: 9

Registration Number: NCT03601507

Locations: 🇺🇸
The University of Arizona Medical Center-University Campus, Tucson, Arizona, United States

Study Evaluating The Role of ClO2 on Mucositis for Pt. Undergoing Head/Neck Radiotherapy

Phase 2

Terminated

Conditions: Head and Neck Carcinoma

Interventions: Other: Laboratory Biomarker Analysis
Drug: Chlorine Dioxide Sterilization
Other: Placebo

First Posted Date: 2018-07-26

Last Posted Date: 2024-03-20

Lead Sponsor: University of Arizona

Target Recruit Count: 14

Registration Number: NCT03602066

Locations: 🇺🇸
The University of Arizona Medical Center-University Campus, Tucson, Arizona, United States

Everolimus in Restoring Salivary Gland Function in Participants With Locally Advanced Head and Neck Cancer Treated With Radiation Therapy

Early Phase 1

Terminated

Conditions: Head and Neck Cancer
Salivary Gland Dysfunction
Xerostomia

Interventions: Drug: Everolimus
Other: Laboratory Biomarker Analysis
Other: Survey Administration

First Posted Date: 2018-07-06

Last Posted Date: 2019-12-02

Lead Sponsor: University of Arizona

Target Recruit Count: 2

Registration Number: NCT03578432

Locations: 🇺🇸
The University of Arizona Cancer Center, Phoenix, Arizona, United States

Investigational Test of a New Sleep Supplement

Not Applicable

Completed

Conditions: Sleep
Mood
Cognitive Performance

Interventions: Other: Control
Dietary Supplement: Proprietary Spearmint Extract Blend

First Posted Date: 2018-06-25

Last Posted Date: 2024-07-18

Lead Sponsor: University of Arizona

Target Recruit Count: 105

Registration Number: NCT03567343

Locations: 🇺🇸
University of Arizona Dept of Psychiatry Research facilities, Tucson, Arizona, United States

Multi-center:The Small (14F) Percutaneous Catheter vs. Large (28-40F) Open Chest Tube for Traumatic Hemothorax (P-CAT)

Not Applicable

Completed

Conditions: The Efficacy of Percutaneous Catheter vs. Open Chest Tube
Traumatic Hemothorax

Interventions: Device: Percutaneous catheter

First Posted Date: 2018-06-06

Last Posted Date: 2021-05-03

Lead Sponsor: University of Arizona

Target Recruit Count: 61

Registration Number: NCT03546764

Locations: 🇺🇸
Medical College of Wisconsin, Milwaukee, Wisconsin, United States
🇺🇸
University of Ariznoa Medican Center, Main campus, Tucson, Arizona, United States
🇺🇸
Emory University, Atlanta, Georgia, United States

and more 1 locations

Nexalin Therapy as a Viable Adjunctive Treatment for Substance Use Disorders

Not Applicable

Active, not recruiting

Conditions: Anxiety
Substance Abuse
Depression
Insomnia

Interventions: Device: TES Treatment
Device: TES-SHAM Treatment

First Posted Date: 2018-05-30

Last Posted Date: 2018-10-11

Lead Sponsor: University of Arizona

Target Recruit Count: 14

Registration Number: NCT03540745

Locations: 🇺🇸
Carrier Clinic, Belle Mead, New Jersey, United States

T-DM1 and Palbociclib for Metastatic HER2 Breast Cancer

Phase 2

Completed

Conditions: HER2 Positive Breast Carcinoma
HER2-positive Breast Cancer
Breast Cancer
Breast Cancer Stage
Recurrent Breast Cancer
Metastatic Breast Cancer

Interventions: Drug: Palbociclib
Drug: T-DM1

First Posted Date: 2018-05-21

Last Posted Date: 2024-08-13

Lead Sponsor: University of Arizona

Target Recruit Count: 55

Registration Number: NCT03530696

Locations: 🇺🇸
Yale Cancer Center, New Haven, Connecticut, United States
🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States
🇺🇸
JPS Health Network, Fort Worth, Texas, United States

and more 13 locations

Effects of Freeze Dried Strawberry Powder Supplementation on Cardiovascular Risk Factors and Gut Microbiome

Not Applicable

Terminated

Conditions: Cardiovascular Risk Factor

Interventions: Dietary Supplement: Strawberry powder
Dietary Supplement: Placebo powder

First Posted Date: 2018-05-14

Last Posted Date: 2024-02-15

Lead Sponsor: University of Arizona

Target Recruit Count: 1

Registration Number: NCT03522974

Locations: 🇺🇸
University of Arizona, Tucson, Arizona, United States

Fluciclovine-PET/CT for Bone Metastases From Prostate Adenocarcinoma

Not Applicable

Completed

Conditions: Prostate Adenocarcinoma

Interventions: Diagnostic Test: F-18 fluciclovine-PET/CT scan

First Posted Date: 2018-04-12

Last Posted Date: 2022-08-16

Lead Sponsor: University of Arizona

Target Recruit Count: 15

Registration Number: NCT03496844

Locations: 🇺🇸
University of Arizona, Tucson, Arizona, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy